D-81
Today is  2024. 09. 08.

Program
Program at a Glance Scientific Program Invited Speakers

09:00 - 10:40 Symposium 1
2024 Guideline Update for Cardiometabolic Disease
09:00 - 10:40
Symposium 1
2024 Guideline Update for Cardiometabolic Disease

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this session; we will provide a comprehensive review of the latest guidelines in key areas of cardiometabolic health from the national key opinion leaders.
  • We will start with the current guidelines for hypertension, followed by updates on the management of dyslipidaemia. We will then look at the latest recommendations for the management of diabetes and conclude with the current guidelines for the management of heart failure.

Chairpersons

09:00 - 09:20

Current Guidelines for Hypertension

Sung Ha Park (Yonsei University, Korea)
09:20 - 09:40

Current Guidelines for Dyslipidemia

Sin Gon Kim (Korea University, Korea)
09:40 - 10:00

Current Guidelines for Diabetes

Byung-Wan Lee (Yonsei University, Korea)
10:00 - 10:20

Current Guidelines for Heart Failure

Seong Mi Park (Korea University, Korea)

10:20 - 10:40

Panel Discussion

Jong-Chan Youn (The Catholic University of Korea, Korea), Minjae Yoon (Seoul National University, Korea)

Jun Hwa Hong (Eulji University, Korea), Suk Jeon (Kyung Hee University, Korea)
10:40 - 11:00

Coffee Break
11:00 - 11:10 Opening Address
11:00 - 11:10
Opening Address
11:10 - 11:50 Plenary Lecture 1
11:10 - 11:50
Plenary Lecture 1
  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), and most often caused by a defect in 3 different genes (LDL-receptor gene, PCSK 9 gene and Apo B gene). As the FH affects the way the body processes cholesterol, people with FH have a higher risk of heart disease and a greater risk of early heart attack. In this plenary lecture, the world renowned expert in FH research, Professor Brian Tomlinson from Macau University of Science and Technology, Macau, China will provide us with beautiful insights and future perspectives in the field of diagnosis and treatment of FH.

Chairpersons

Won-Young Lee (Sungkyunkwan University, Korea)
11:10 - 11:50

Familial Hypercholesterolaemia, Diagnosis and Management

Brian Tomlinson (Macau University of Science and Technology, Macao SAR)
11:50 - 12:10 Luncheon Symposium 1 [ Daewoong Pharmaceutical ]
11:50 - 12:10
Luncheon Symposium 1 [ Daewoong Pharmaceutical ]

Chairperson

TBD
11:50 - 12:10

TBD
12:10 - 13:00

Break
13:00 - 14:40 Symposium 3
Non-Atherosclerotic, Non-Cardioembolic Cerebral Infarction
13:00 - 14:40
Symposium 3
Non-Atherosclerotic, Non-Cardioembolic Cerebral Infarction

Organizer : Sang-Mi Noh (The Catholic University of Korea, Korea)

  • Ischemic stroke is a disease with a variety of etiologies. Most of its cases are due to atherosclerosis which is influenced by traditional vascular risk factors such as diabetes and hypertension or, due to high-risk cardio-embolic sources such as atrial fibrillation.
  • There are well-established guidelines and extensive research concerning the causes and treatment of these types of strokes. In this session, we aim to share the latest research and clinical experiences on non-atherosclerotic, non-cardio-embolic stroke which are rare, yet require different therapeutic approaches.

Chairpersons

Hyung Min Kwon (Seoul National University, Korea)
Yo Han Jung (Yonsei University, Korea)
13:00 - 13:20

Cervicocephalic arterial dissections

Seong Joon Lee (Ajou University, Korea)
13:20 - 13:40

Antiphospholipid syndrome and stroke

Wookjin Yang (Seoul National University, Korea)
13:40 - 14:00

Cancer-related Stroke

TBD

14:00 - 14:20

Characteristics of PFO-related Stroke and its Secondary Prevention

Hyung Jun Kim (Sungkyunkwan University, Korea)
14:20 - 14:40

Panel Discussion

Jin Jung (The Catholic University of Korea, Korea), Ho Geol Woo (Kyung Hee University, Korea)

Seong heon Kim (Kangwon National University, Korea), Jong Moo Park (Eulji University, Korea)
14:40 - 15:00

Coffee Break
15:00 - 15:40 Plenary Lecture 2
15:00 - 15:40
Plenary Lecture 2
  • Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. In this plenary lecture, Prof. Takayoshi Ohkubo from Teikyo University School of Medicine, Japan will give us a wonderful lecture on the current knowledge and his experience in Japan on significance of home blood pressure measurement.

Chairpersons
15:00 - 15:40

Significance of Home Blood Pressure Measurement : Perspectives from Experience In Japan

Takayoshi Ohkubo (Teikyo University School of Medicine, Japan)
15:40 - 17:20 Symposium 5
KSCP-ASPC Joint Session: Comprehensive Cardiovascular Health: Risks and Prevention Strategies
15:40 - 17:20
Symposium 5
KSCP-ASPC Joint Session: Comprehensive Cardiovascular Health: Risks and Prevention Strategies

Organizer : Hyeon Chang Kim (Yonsei University, Republic of Korea)

  • Comprehensive Approach in Cardiovascular Prevention, a special event from the collaboration between the American Society for Preventive Cardiology (ASPC) and the Korean Society of Cardiovascular Disease Prevention (KSCP).
  • This session will highlight innovative strategies for preventing cardiovascular disease. Dr. Heather M. Johnson will discuss the link between adverse pregnancy outcomes and cardiovascular disease.
  • Dr. Jong Chan Yoon will explore prevention strategies for cardiovascular disease among cancer survivors. Dr. Charles German will highlight the role of physical activity measurement in risk assessment, and Dr. Hyeon Chang Kim will address the impact of socioeconomic factors on cardiovascular health.
  • This joint session offers a unique opportunity to learn from leading experts and advance your knowledge of cardiovascular prevention. Don’t miss out on these valuable insights and discussions.

Chairpersons

Heather M. Johnson (Florida Atlantic University, USA)
Dae Jung Kim (Ajou University, Korea)

15:40 - 16:00

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

Heather M. Johnson (Florida Atlantic University, USA)
16:00 - 16:20

Prevention of Cardiovascular Disease among Cancer Survivors

Mi-Hyang Jung (The Catholic University of Korea, Korea)
16:20 - 16:40

Measurement of Physical Activity for Cardiovascular Disease Risk Assessment

Charles German (University of Chicago, USA)
16:40 - 17:00

Measurement of Socioeconomic Factors for Cardiovascular Disease Risk Assessment

Hyeon Chang Kim (Yonsei University, Korea)
17:00 - 17:20

Panel Discussion

Ho Kyu Lee (Yonsei University, Korea), Dae Young Chun (Hallym University, Korea)

TBD, Song Vogue Ahn (Ewha Womans University, Korea)
17:20 - 18:00 Satellite Symposium 1 [ Yuhan & Hanmi Pharmaceutical ]
17:20 - 18:00
Satellite Symposium 1 [ Yuhan & Hanmi Pharmaceutical ]

Chairpersons

TBD
17:20 - 17:40

TBD
17:40 - 18:00

TBD
09:00 - 10:40 Symposium 2
Updates on Novel Drugs in the Field of Diabetes and Obesity
09:00 - 10:40
Symposium 2
Updates on Novel Drugs in the Field of Diabetes and Obesity

Chairpersons

Jung Hyun Noh (Inje University, Korea)
Seong Hun Choi (Hallym University, Korea)
09:00 - 09:20

SGLT1/2 Dual Inhibitor

Eun-Jung Rhee (Sungkyunkwan University, Korea)
09:20 - 09:40

Cardiovascular Effects of Tirzepatide

Clare Lee (Eli Lilly and Company, U.S.A)
09:40 - 10:00

Transforming Obesity Care: Next-Gen Treatments for Weight Loss

Jang Won Son (The Catholic University of Korea, Korea)
10:00 - 10:20

Weekly Insulin: Pharmacokinetics/Dosing Strategy and Clinicaloutcome

Se Eun Park (Sungkyunkwan University, Korea)
10:20 - 10:40

Panel Discussion

Yoo Jin Han (Keimyung University, Korea), TBD

TBD, TBD
10:40 - 11:00

Coffee Break
11:00 - 11:10 Opening Address
11:00 - 11:10
Opening Address
11:10 - 11:50 Plenary Lecture 1
11:10 - 11:50
Plenary Lecture 1
  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), and most often caused by a defect in 3 different genes (LDL-receptor gene, PCSK 9 gene and Apo B gene). As the FH affects the way the body processes cholesterol, people with FH have a higher risk of heart disease and a greater risk of early heart attack. In this plenary lecture, the world renowned expert in FH research, Professor Brian Tomlinson from Macau University of Science and Technology, Macau, China will provide us with beautiful insights and future perspectives in the field of diagnosis and treatment of FH.

Chairpersons

Won-Young Lee (Sungkyunkwan University, Korea)
11:10 - 11:50

Familial Hypercholesterolaemia, Diagnosis and Management

Brian Tomlinson (Macau University of Science and Technology, Macao SAR)
11:50 - 12:30 Luncheon Symposium 2 [ LG Chem & Dong-A ST ]
11:50 - 13:00
Luncheon Symposium 2 [ LG Chem & Dong-A ST ]

Chairperson

TBD
11:50 - 12:10

TBD
12:10 - 12:30

TBD
12:10 - 13:00

Break
13:00 - 14:40 Symposium 4
Chronic Diseases/Cardiovascular Diseases in the Elderly
13:00 - 14:40
Symposium 4

Chairpersons
13:00 - 13:20

Medical Problems and Costs in Korean Elderly

Seok-Jun Yoon (Korea University, Korea)
13:20 - 13:40

Cardiovascular Diseases in the Elderly

Kwang-il Kim (Seoul National University, Korea)
13:40 - 14:00

Diabetes in the Elderly

Jae Seung Yun (The Catholic University of Korea, Korea)
14:00 - 14:20

Stroke in the Elderly

Chi Kyung Kim (Korea University, Korea)
14:20 - 14:40

Panel Discussion

Eun Joo Lee (University of Ulsan, Korea), TBD

TBD, TBD
14:40 - 15:00

Coffee Break
15:00 - 15:40 Plenary Lecture 2
15:00 - 15:40
Plenary Lecture 2
  • Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. In this plenary lecture, Prof. Takayoshi Ohkubo from Teikyo University School of Medicine, Japan will give us a wonderful lecture on the current knowledge and his experience in Japan on significance of home blood pressure measurement.

Chairpersons
15:00 - 15:40

Significance of Home Blood Pressure Measurement : Perspectives from Experience In Japan

Takayoshi Ohkubo (Teikyo University School of Medicine, Japan)
15:40 - 17:20 Symposium 6
Integrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes
15:40 - 17:20
Symposium 6
ntegrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes

Organizer : Eun Hui Bae (Chonnam National University, Republic of Korea)

  • Integrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes, must attend the session at our upcoming conference.
  • This session will cover innovative therapeutic strategies for managing CKD with hypertension, presenting the latest updates in hypertension guidelines.
  • It will also delve into the newest guidelines for dyslipidemia management in CKD, focusing on practical applications to optimize lipid control and reduce cardiovascular risk.
  • Additionally, the symposium will explore prevention and early intervention strategies in diabetic kidney disease, highlighting the latest guidelines which aimed at delaying disease progression.
  • Furthermore, the session will discuss how artificial intelligence is being leveraged to advance research in hypertension, showcasing AI-driven innovations that have the potential to revolutionize hypertension management.
  • Don’t miss this opportunity to enhance your knowledge and clinical practice in managing CKD and its associated conditions.
  • We look forward to your participation!

Chairpersons

Bum Soon Choi (The Catholic University of Korea, Korea)
TBD
15:40 - 16:00

Innovative Therapeutic Strategies in CKD with Hypertension: Update in HTN Guideline in CKD

Jeonghwan Lee (Seoul National University, Korea)
16:00 - 16:20

Latest Guidelines for Dyslipidemia Management in CKD: Update in Dyslipidemia Guideline in CKD

Tae Hyun Ban (The Catholic University of Korea, Korea)
16:20 - 16:40

Prevention and Early Intervention in Diabetic Kidney Disease: Update Guideline in DKD

Su Hyun Song (Chonnam National University, Korea)
16:40 - 17:00

Leveraging AI for Hypertension Research Advances

Jae Boum Youm (Inje University, Korea)
17:00 - 17:20

Panel Discussion

Eun Hui Bae (Chonnam National University, Korea), Dae Eun Choi (Chungnam National University, Korea)

Su Hyun Kim (Chung-Ang University, Korea), Won Min Hwang (Konyang University, Korea)
17:20 - 18:00 Satellite Symposium 2 [HK inno.N & JW Pharmaceutical ]
17:20 - 18:00
Satellite Symposium 2 [HK inno.N & JW Pharmaceutical ]

Chairpersons

TBD
17:20 - 17:40

TBD
17:40 - 18:00

TBD